ARCT

Arcturus Therapeutics Holdings Inc

$6.98

0.10 (1.47%) Today

0.26 (3.87%) After-hours

— up— down

Compare ARCT

Market Cap

$191M-48.3%

Revenue (TTM)

$54.71M-61.9%

Net Income (TTM)

$-80,027,878

EPS (TTM)

-2.82

Shares Out

28.42M

Open

$6.72

Previous Close

$6.82

Day Range

$6.69 – $6.99

52-Week Range

$5.85 – $24.17

Beta

2.38

Volume

394.07K

Avg Volume

454.76K

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About ARCT

Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA (siRNA), messenger RNA (mRNA), gene editing RNA, DNA, antisense oligonucleotides, and microRNA.